MIR4767: A Potential Drug Target and Biomarker (G100616467)
MIR4767: A Potential Drug Target and Biomarker
MIR4767, also known as interleukin-4767, is a protein that is expressed in various tissues throughout the body. It is a member of the interleukin-4 family, which includes other proteins such as IL-1, IL-2, and IL-12. MIR4767 has been shown to play a role in various biological processes, including immune response, inflammation, and tissue repair. As a result, MIR4767 has potential as a drug target and biomarker.
The interleukin-4 family of proteins is involved in the regulation of immune responses and inflammation. MIR4767 is a key member of this family, as it has been shown to play a role in the regulation of T cell development and function. MIR4767 is a 24-kDa protein that is expressed in various tissues, including the skin, lungs, heart, kidneys, and intestine. It is composed of a unique N-terminal region that is involved in its stability and functions, as well as a C-terminal region that contains a putative N-endopeptidease (NEDP) domain.
NEDP is a protein that is involved in the detoxification of damaged or unnecessary proteins. It is thought to play a role in the regulation of various cellular processes, including cell survival, apoptosis, and inflammation. The NEDP domain of MIR4767 is involved in the catalytic activity of this protein, as well as its ability to interact with other proteins.
MIR4767 has been shown to play a role in the regulation of T cell development and function. T cells are a type of immune cell that play a critical role in protecting the body against infection and disease. MIR4767 has been shown to regulate the development and function of T cells by controlling the production of cytokines, which are proteins that play a critical role in immune responses. In addition, MIR4767 has been shown to regulate the expression of genes involved in T cell development and function.
MIR4767 has also been shown to play a role in the regulation of inflammation. Inflammation is a critical response of the immune system to injury or infection. MIR4767 has been shown to regulate the production of pro-inflammatory cytokines, as well as the production of anti-inflammatory cytokines. This suggests that MIR4767 may play a role in the regulation of chronic inflammation, which can lead to a range of diseases, including heart disease, diabetes, and cancer.
In addition to its role in immune response and inflammation, MIR4767 has also been shown to play a role in tissue repair. Tissue repair is a critical process that occurs in the body after injury or trauma. MIR4767 has been shown to regulate the production of pro-inflammatory cytokines, as well as the production of anti-inflammatory cytokines, during the tissue repair process. This suggests that MIR4767 may play a role in the regulation of tissue repair and regeneration.
Given the various roles that MIR4767 has been shown to play in various biological processes, it has potential as a drug target. The development of compounds that can specifically target MIR4767 and modulate its activity may provide new treatments for a range of diseases. Additionally, the study of MIR4767 may also provide new insights into the regulation of immune responses and inflammation.
In conclusion, MIR4767 is a protein that has been shown to play a role in various biological processes, including immune response, inflammation, and tissue repair. Its unique N-terminal and C-terminal regions, as well as its involvement in the regulation of T cell development and function, make it a potential drug target. Further research is needed to fully understand the
Protein Name: MicroRNA 4767
The "MIR4767 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4767 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR4768 | MIR4769 | MIR4770 | MIR4771-1 | MIR4771-2 | MIR4772 | MIR4773-1 | MIR4773-2 | MIR4774 | MIR4775 | MIR4776-1 | MIR4776-2 | MIR4777 | MIR4778 | MIR4779 | MIR4780 | MIR4781 | MIR4782 | MIR4783 | MIR4784 | MIR4785 | MIR4786 | MIR4787 | MIR4789 | MIR4790 | MIR4791 | MIR4793 | MIR4794 | MIR4795 | MIR4796 | MIR4797 | MIR4798 | MIR4799 | MIR4800 | MIR4802 | MIR4803 | MIR4804 | MIR483 | MIR484 | MIR485 | MIR486-1 | MIR486-2 | MIR487A | MIR487B | MIR488 | MIR489 | MIR490 | MIR491 | MIR492 | MIR493 | MIR494 | MIR495 | MIR496 | MIR497 | MIR497HG | MIR498 | MIR4999 | MIR499A | MIR499B | MIR5000 | MIR5001 | MIR5002 | MIR5003 | MIR5004 | MIR5006 | MIR5007 | MIR5008 | MIR5009 | MIR500A | MIR500B | MIR501 | MIR5010 | MIR5011 | MIR502 | MIR503 | MIR503HG | MIR504 | MIR5047 | MIR505 | MIR506 | MIR507 | MIR508 | MIR5088 | MIR5089 | MIR509-1 | MIR509-2 | MIR509-3 | MIR5090 | MIR5091 | MIR5092 | MIR5093 | MIR5094 | MIR510 | MIR5100 | MIR511 | MIR511-2 | MIR512-1 | MIR512-2 | MIR513A1 | MIR513A2
